Navigation Links
ITN's TrialShare wins National Academies Board on Research Data and Information challenge
Date:7/17/2014

Seattle, WA (July 16, 2014) The Immune Tolerance Network's (ITN) TrialShare Clinical Trials Research Portal has won the National Academy of Sciences Data and Information Challenge. The theme of this year's competition, launched and judged by the academy's Board on Research Data and Information (BDRI), was "Using Data for the Public Good."

The ITN's entry, entitled "ITN TrialShare: Enabling True Clinical Trial Transparency" describes the unique data sharing portal developed by the NIH-sponsored clinical research consortium. The system provides clinical trial investigators an unprecedented ability to share data with other researchers. Among its unique features are the ability to access raw de-identified participant level study data, review published analysis methods, and perform real-time interactive graphical analyses in collaboration with other researchers.

The BRDI Data and Information Challenge was created by the National Academy of Sciences as a means of increasing awareness of current issues surrounding the collection and use of scientific research data, including accessibility, integration, and reproducibility; as well as promoting new opportunities for novel analyses, allowing for maximum societal benefit from the available data.

With a number of high profile drug failures in the past decade, there is a growing movement within government, industry, and academia for greater transparency in the reporting of clinical trial results. Substantial progress has been made in reaching consensus on the need for change; however a number of technical and procedural challenges have limited the ability to implement effective solutions. ITN TrialShare has been created to specifically address many of these issues.

"Modern clinical trial data is highly complex, often including information related to genetic testing and other high throughput techniques that generate a lot of data," says Adam Asare, ITN Director of Bioinformatics. "What we've done is create a set of intuitive tools that allow researchers to share and analyze their data in multiple ways you can be an expert statistician or a novice, and find what you need."

Anyone with a valid email address can self-create a free ITN TrialShare account in minutes and start accessing hundreds of datasets for dozens of completed studies, data and analyses. ITN TrialShare currently has data and specimen bio-repository information associated with 35 trials and 3,200 participants available to the public in the therapeutic areas of transplant, allergy, autoimmunity, and type I diabetes. ITN makes the underlying data from all published and closed studies, regardless of outcome, available through TrialShare. ITN TrialShare was built and customized using the LabKey Server open source framework.


'/>"/>

Contact: Philip Bernstein
ITNCommunications@immunetolerance.org
240-235-6132
Immune Tolerance Network
Source:Eurekalert

Related biology news :

1. Researchers at LSTM crack the genetic secret of mosquito resistance to DDT and ITNs
2. National Xenopus resource at the MBL innovates new way to study proteins
3. Registration is now open for the HFES 2014 International Annual Meeting
4. Largest International Meeting for the Study of Reproductive Biology Attracts Researchers from 36 Countries in Grand Rapids, Michigan
5. International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019
6. National Electronic ID Programs Generate $54 Billion Between 2013 and 2018 with 3.5 Billion National eID Card Holders Worldwide
7. Marshall University to partner with international company in drug development venture
8. UC Riverside plant pathologist receives national recognition
9. Highlights for 2014 national meeting of worlds largest scientific society
10. The ICIST-KAIST International Conference 2014 from August 4-8, 2014 in Korea
11. International Tree Nut Council study results may help people with type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... the first robotic gym for the rehabilitation and functional motor sense evaluation ... Genoa, Italy . The first 30 robots will be available from ... . The technology was developed and patented at the IIT laboratories ... Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:5/6/2017)... SINGAPORE , May 5, 2017 ... has just announced a new breakthrough in biometric ... that exploits quantum mechanical properties to perform ... new smart semiconductor material created by Ram Group ... across finance, entertainment, transportation, supply chains and security. ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
Breaking Biology Technology: